Prepared by R.R. Donnelley Financial -- Form 8-K
 

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)         September 4, 2002        
 
Natus Medical Incorporated

(Exact name of registrant as specified in its charter)
 
Delaware

 
000-33001

 
77-0154833

(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
1501 Industrial Road, San Carlos, California 94070

(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code:         (650) 802-0400        
 
Not applicable

(Former name or former address, if changed since last report)
 


 
ITEM 5.    OTHER EVENTS.
 
On September 5, 2002, Natus Medical Incorporated (“Natus”) announced that its board of directors had approved the adoption of a stockholder rights plan. A copy of Natus’ press release is attached hereto.
 
 
ITEM 7.    FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
 
(c)    Exhibits.
 
Exhibit No.

  
Description

99.1
  
Press Release dated September 5, 2002.
 

2


 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: September 6, 2002
     
NATUS MEDICAL INCORPORATED
           
By:
 
/s/    TIM C. JOHNSON        

               
Tim C. Johnson
President, Chief Executive Officer and Chief Operating Officer

3


 
Index to Exhibits
Exhibit No.

  
Description

99.1
  
Press Release dated September 5, 2002.

4